Biotricity, Inc. - Condensed Consolidated Balance Sheets - USD ($)		Dec. 31, 2017	Mar. 31, 2017
CURRENT ASSETS
Cash		$ 2,482,262	$ 424,868
Harmonized sales tax recoverable		27,991	939
Deposits and other receivables		29,682	14,705
Total Current Assets		2,539,935	440,512
Deposits and other receivables		33,000	33,000
Total Assets		2,572,935	473,512
Current Liabilities:
Accounts payable and accrued liabilities	[1]	630,089	1,137,454
Convertible promissory note	[2]		1,556,990
Derivative liabilities	[3]		2,163,884
TOTAL LIABILITIES		630,089	4,858,328
Stockholders' Equity (Deficiency)
Preferred stock	[4]	1	1
Common stock	[5]	31,531	27,199
Shares to be issued	[6]	601,729
Additional paid-in capital		25,594,234	14,308,583
Accumulated other comprehensive loss		(628,694)	(413,384)
Accumulated deficit		(23,655,955)	(18,307,215)
TOTAL STOCKHOLDERS' EQUITY (DEFICIENCY)		1,942,846	(4,384,816)
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIENCY)		2,572,935	473,512
Commitments	[7]
Subsequent Events	[8]

[1] See Note 4

[2] See Note 5

[3] See Note 6

[4] $0.001 par value; 10,000,000 shares authorized as at December 31, 2017 and March 31, 2017, respectively, 1 share issued and outstanding as at December 31, 2017 and March 31, 2017, respectively. [Note 7]

[5] $0.001 par value; 125,000,000 authorized as at December 31, 2017 and March 31, 2017, respectively. Issued and outstanding common shares: 22,407,274 as at December 31, 2017 and 18,075,848 as at March 31, 2017, respectively, and exchangeable shares of 9,123,031 outstanding as at December 31, 2017 and March 31, 2017, respectively. [Note 7]

[6] See Note 7

[7] See Note 9

[8] See Note 10